Summary
Updated Aug 31, 2026
Joel David Mayersohn is Director of CITIUS ONCOLOGY, INC. (CTOR). 5 SEC Form 4 filings on record going back to 2024, most recently on 22 December 2025.
Recent Transactions
4Every recent SEC Form 4 transaction Joel David Mayersohn has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Joel David Mayersohn's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Vivek Ramaswamy - $60.40M of ROIV open-market activity in the last 12 months
- David Cordani - $60.11M of CI open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $60.00M of KOD open-market activity in the last 12 months
- Deep Track Biotechnology Master Fund, Ltd. - $60.00M of LBRX open-market activity in the last 12 months
- AI DMI LLC - $59.87M of IRON open-market activity in the last 12 months
- John E. Kao - $58.58M of ALHC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Joel David Mayersohn?
Joel David Mayersohn is a corporate insider, tracked as Director of CITIUS ONCOLOGY, INC. (CTOR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Joel David Mayersohn last file a Form 4?
The most recent primary Form 4 on record is dated 22 December 2025, one of 5 filings going back to 2024.
Where can I see all of Joel David Mayersohn's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Joel David Mayersohn and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
